DK3724319T3 - Fremgangsmåder til opnåelse af muskelafledte celler - Google Patents

Fremgangsmåder til opnåelse af muskelafledte celler Download PDF

Info

Publication number
DK3724319T3
DK3724319T3 DK18815731.7T DK18815731T DK3724319T3 DK 3724319 T3 DK3724319 T3 DK 3724319T3 DK 18815731 T DK18815731 T DK 18815731T DK 3724319 T3 DK3724319 T3 DK 3724319T3
Authority
DK
Denmark
Prior art keywords
methods
derived cells
obtaining muscle
muscle
obtaining
Prior art date
Application number
DK18815731.7T
Other languages
English (en)
Inventor
Marco Thurner
Eva Margreiter
Wolfgang Schwaiger
Faheem Muhammad Asim
Rainer Marksteiner
Original Assignee
Innovacell Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=60923243&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK3724319(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Innovacell Ag filed Critical Innovacell Ag
Application granted granted Critical
Publication of DK3724319T3 publication Critical patent/DK3724319T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/34—Muscles; Smooth muscle cells; Heart; Cardiac stem cells; Myoblasts; Myocytes; Cardiomyocytes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0658—Skeletal muscle cells, e.g. myocytes, myotubes, myoblasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/50—Cell markers; Cell surface determinants
    • C12N2501/599—Cell markers; Cell surface determinants with CD designations not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/70—Enzymes
    • C12N2501/71—Oxidoreductases (EC 1.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2509/00—Methods for the dissociation of cells, e.g. specific use of enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2509/00—Methods for the dissociation of cells, e.g. specific use of enzymes
    • C12N2509/10—Mechanical dissociation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Rheumatology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
DK18815731.7T 2017-12-14 2018-12-14 Fremgangsmåder til opnåelse af muskelafledte celler DK3724319T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP17207417 2017-12-14
PCT/EP2018/085015 WO2019115790A1 (en) 2017-12-14 2018-12-14 Methods for obtaining muscle derived cells

Publications (1)

Publication Number Publication Date
DK3724319T3 true DK3724319T3 (da) 2023-05-01

Family

ID=60923243

Family Applications (1)

Application Number Title Priority Date Filing Date
DK18815731.7T DK3724319T3 (da) 2017-12-14 2018-12-14 Fremgangsmåder til opnåelse af muskelafledte celler

Country Status (24)

Country Link
US (2) US11617768B2 (da)
EP (2) EP4223872A3 (da)
JP (2) JP7361398B2 (da)
KR (1) KR20200099173A (da)
CN (1) CN111448307A (da)
AU (1) AU2018383015A1 (da)
BR (1) BR112020011853A2 (da)
CA (1) CA3085483A1 (da)
CL (1) CL2020001480A1 (da)
CY (1) CY1126049T1 (da)
DK (1) DK3724319T3 (da)
ES (1) ES2948712T3 (da)
FI (1) FI3724319T3 (da)
HR (1) HRP20230474T1 (da)
HU (1) HUE062005T2 (da)
IL (2) IL309687A (da)
LT (1) LT3724319T (da)
MX (1) MX2020005881A (da)
PL (1) PL3724319T3 (da)
PT (1) PT3724319T (da)
RS (1) RS64241B1 (da)
SI (1) SI3724319T1 (da)
WO (1) WO2019115790A1 (da)
ZA (1) ZA202002410B (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4026587A4 (en) * 2019-09-30 2022-11-16 TERUMO Kabushiki Kaisha METHOD OF INCREASING THE PERCENTAGE OF CD56+ CELLS
WO2023012334A1 (en) 2021-08-06 2023-02-09 Innovacell Ag Myogenic progenitor cells for use in an optimized method for the prevention and treatment of anal incontinence
WO2024115761A1 (en) * 2022-12-01 2024-06-06 Universität Zürich Method of preparing a mass culture of muscle precursor cells (mpcs) and uses thereof
KR20240085728A (ko) * 2022-12-08 2024-06-17 주식회사 팡세 근육줄기세포의 분화능 예측을 위한 cd56의 용도

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5130141A (en) 1988-05-24 1992-07-14 Law Peter K Compositions for and methods of treating muscle degeneration and weakness
US5538722A (en) 1989-06-13 1996-07-23 Stanford University Isolation, growth, differentiation and genetic engineering of human muscle cells
AU5159901A (en) 2000-04-14 2001-10-30 Univ Pittsburgh Soft tissue and bone augmentation and bulking utilizing muscle-derived progenitor cells, compositions and treatments thereof
JPWO2003027281A1 (ja) 2001-09-20 2005-01-06 協和醗酵工業株式会社 骨格筋間質由来多分化能幹細胞
CN1812800B (zh) * 2003-04-25 2013-01-16 匹兹堡大学 用于促进和增强神经修复和再生的肌肉来源的细胞(mdc)
FR2890977A1 (fr) * 2005-09-19 2007-03-23 Assist Publ Hopitaux De Paris Procede d'obtention de cellules musculaires lisses humaines et leurs applications
WO2007106200A2 (en) * 2006-01-10 2007-09-20 Theradigm, Inc. Expansion and differentiation of neural stem cells under low oxygen conditions
US20090155221A1 (en) * 2007-05-29 2009-06-18 Thomas Payne Bone augmentation utilizing muscle-derived progenitor compositions, and treatments thereof
EP2206774A1 (en) 2008-12-23 2010-07-14 Genzyme Corporation Muscle-derived cells having differentiation capacities
CN106350480B (zh) * 2016-08-26 2019-11-08 中国农业科学院北京畜牧兽医研究所 一种纯化牛胎儿骨骼肌组织来源成肌细胞的方法
KR20220002315A (ko) 2019-03-22 2022-01-06 이노바셀 아게 유도된 평활근 세포를 수득하는 방법

Also Published As

Publication number Publication date
PT3724319T (pt) 2023-06-07
JP2023085507A (ja) 2023-06-20
WO2019115790A1 (en) 2019-06-20
HUE062005T2 (hu) 2023-09-28
RU2020120580A (ru) 2022-01-14
IL275288A (en) 2020-07-30
FI3724319T3 (fi) 2023-05-04
ZA202002410B (en) 2021-09-29
EP4223872A2 (en) 2023-08-09
ES2948712T3 (es) 2023-09-18
JP7494430B2 (ja) 2024-06-04
US20210069255A1 (en) 2021-03-11
CY1126049T1 (el) 2023-11-15
JP7361398B2 (ja) 2023-10-16
MX2020005881A (es) 2020-08-13
CN111448307A (zh) 2020-07-24
JP2021506285A (ja) 2021-02-22
CA3085483A1 (en) 2019-06-20
US11617768B2 (en) 2023-04-04
BR112020011853A2 (pt) 2020-11-24
CL2020001480A1 (es) 2020-10-30
AU2018383015A1 (en) 2020-05-28
EP3724319B1 (en) 2023-04-05
EP4223872A3 (en) 2023-08-23
EP3724319A1 (en) 2020-10-21
IL309687A (en) 2024-02-01
HRP20230474T1 (hr) 2023-07-21
LT3724319T (lt) 2023-06-12
RS64241B1 (sr) 2023-06-30
PL3724319T3 (pl) 2023-07-24
KR20200099173A (ko) 2020-08-21
SI3724319T1 (sl) 2023-07-31
US20230285467A1 (en) 2023-09-14

Similar Documents

Publication Publication Date Title
DK3315610T3 (da) Fremgangsmåde til fremstilling af fucosylerede oligosaccharider
DK3292134T3 (da) Metode til dyrkning af akkermansia
DK3668851T3 (da) Fremgangsmåde til fremstilling af thiocarbonater
DK3192902T3 (da) Fremgangsmåde til fremstilling af graphenholdige viscosefibre
DK3325443T3 (da) Fremgangsmåde til fremstilling af pridopidin
DK3402773T3 (da) Fremgangsmåde til fremstilling af methanol
DK3317400T3 (da) Fremgangsmåde til kryokonservering af tumorinfiltrerende lymfocytter
DK3347450T3 (da) Ex vivo-proliferation af epithelceller
DK3259349T3 (da) Dehydrogenase-katalyseret fremstilling af FDCA
DK3307271T3 (da) Fremgangsmåder til anvendelse af pyruvatkinase-aktivatorer
DK3368683T3 (da) Fremgangsmåde til kvantifikationen af pd-l1
DK3580330T3 (da) Fremgangsmåde til generering af t-celleprogenitorer
DK3515990T3 (da) Fremgangsmåde til fremstilling af lignocellulosematerialer
DK3370949T3 (da) Sammensætning af tætningsmiddel
DK3724319T3 (da) Fremgangsmåder til opnåelse af muskelafledte celler
DK3487443T3 (da) Fremgangsmåde til opmåling af en implantat-implantat-situation
DK3280408T3 (da) Fremgangsmåde til fremstilling af dicycloplatin
DK3460102T3 (da) Fremgangsmåde til fremstilling af en elektrokatalysator
DK3380721T3 (da) Forbedringer relateret til fremstillingen af vindmøllevinger
DK3538960T3 (da) Sekvens styring af programmoduler
DK3612845T3 (da) Fremgangsmåde til kontaktløs bestemmelse af flowparametre
DK3626814T3 (da) Fremstilling af cellesfæroider
DK3548427T3 (da) Fremgangsmåde til fremstilling af hydrogen
DK3137449T3 (da) Fremgangsmåder til fremstilling af substituerede cycloseriner
DK3729441T3 (da) Påvisning af mikrosatellit instabilitet